San Francisco Bay Area biotech venture Humanigen, Inc. (HGEN), formerly known as KaloBios Pharmaceuticals, is a clinical stage company focused on preventing and treating cytokine storm with lenzilumab, their proprietary Humaneered® anti-human granulocyte...
GM-CSF
Category
University of Zurich Grants Exclusive Worldwide License to Humanigen for the Prevention of GvHD through GM-CSF Neutralization
The University of Zurich has granted Humanigen an exclusive license for the prevention of GvHD (Graft-versus-Host Disease) through GM-CSF Neutralization. This deal helps Humanigen expand its extensive intellectual property portfolio to include prevention of...